Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.89 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9016049 | 1.00 | MEN1 (0.89) | MEN1KMT2ATDP1 | |
| SCHEMBL9560251 | 0.95 | MEN1 (0.80) | MEN1KMT2ATDP1 | |
| SCHEMBL4881275 | 0.95 | MEN1 (0.80) | MEN1KMT2ATDP1 | |
| Perflunafene SCHEMBL63605 | 0.94 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| Perflunafene SCHEMBL63606 | 0.94 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| Perflunafene SCHEMBL1069193 | 0.94 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| SCHEMBL2476658 | 0.94 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| SCHEMBL15755574 | 0.94 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| Perflunafene SCHEMBL4418110 | 0.94 | MEN1 (1.00) | MEN1KMT2ATDP1 | |
| SCHEMBL10889508 | 0.94 | MEN1 (1.00) | MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8753606-B2 | Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-06-17 | — | — | US | claimed |
| US-8734762-B2 | Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-05-27 | — | — | US | claimed |
| US-20110110867-A1 | MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2011-05-12 | — | — | US | claimed |
| US-20100233094-A1 | PERFLUOROCARBON NANO-EMULSION CONTAINING QUANTUM DOT NANOPARTICLES AND METHOD FOR PREPARING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH (KR) | 2010-09-16 | — | — | US | claimed |
| WO-2009154425-A9 | MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2010-03-18 | — | — | WO | claimed |
| WO-2009154425-A2 | MULTIMODAL IMAGING METHOD USING NANO-EMULSION COMPRISING OPTICAL NANO-PARTICLES AND PERFLUOROCARBONS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-12-23 | — | — | WO | claimed |
| WO-2009051337-A1 | PERFLUOROCARBON NANO-EMULSION CONTAINING QUANTUM DOT NANOPARTICLES AND METHOD FOR PREPARING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-04-23 | — | — | WO | claimed |
| US-20240307364-A1 | GAS TRANSMISSION EMULSION FOR INTRAVENOUS ADMINISTRATION | ARSHINTSEVA ELENA VALENTINOVNA (RU) | 2024-09-19 | — | — | US | disclosed |
| CN-107922843-B | Material composition | 默克专利股份有限公司 | 2021-12-10 | — | — | CN | disclosed |
| EP-3334801-B1 | MATERIAL COMBINATION | MERCK PATENT GMBH (DE) | 2020-05-27 | — | — | EP | disclosed |
| US-20180237696-A1 | MATERIAL COMBINATION | MERCK PATENT GMBH (DE) | 2018-08-23 | — | — | US | disclosed |
| EP-3334801-A1 | MATERIAL COMBINATION | Merck Patent GmbH (DE) | 2018-06-20 | — | — | EP | disclosed |
| WO-2017025167-A1 | MATERIAL COMBINATION | MERCK PATENT GMBH (DE) | 2017-02-16 | — | — | WO | disclosed |
| EP-0089232-B1 | PERFLUOROCARBON LIQUIDS USEFUL IN EYE TREATMENT AND DIAGNOSTIC PROCEDURES | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1986-07-02 | — | — | EP | disclosed |
| US-4490351-A | REPLACEMENT FOR VITREOUS AND AQUEOUS; TRANSPARENTIZES LENS AND CORNEA; SURGERY; MEDICAL DIAGNOSIS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0112658-A2 | Extraocular device for treating the eye | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1984-07-04 | — | — | EP | disclosed |
| US-4452818-A | Extraocular method of treating the eye with liquid perfluorocarbons | HAIDT STERLING J (US) | 1984-06-05 | — | — | US | disclosed |
| US-4443480-A | PERFLUOROCYCLOCARBON, AMINE OXIDE | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1984-04-17 | — | — | US | disclosed |
| EP-0091820-A1 | Artificial blood and other gas transport agents | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1983-10-19 | — | — | EP | disclosed |
| EP-0089232-A2 | Perfluorocarbon liquids useful in eye treatment and diagnostic procedures | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1983-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240307364-A1 | GAS TRANSMISSION EMULSION FOR INTRAVENOUS ADMINISTRATION | PAOX, SLCO4C1, SLCO2A1 | MEN1 4474/4885KMT2A 4446/4885TDP1 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.